Nuobikan Releases Updated Board and Committee Composition; Liao Yu Confirmed as Chairman

Bulletin Express
Jun 10

Nuobikan Artificial Intelligence Technology (Chengdu) Co., Ltd. disclosed its latest corporate governance lineup on 10 June 2026.

The Board now comprises 10 directors—4 executive, 2 non-executive and 4 independent non-executive members. Executive Director Liao Yu continues to serve as Chairman alongside fellow executives Tang Taike, Liu Bo and Wang Li. Non-executive seats are held by Luo Tian and Hua Zhangrong, while independent non-executive positions are occupied by Cao Xiaoxue, Sang Yongsheng, Bau Siu Fung and Wang Huan.

Committee structures and leadership are as follows: • Audit Committee: Chaired by independent director Cao Xiaoxue, with Bau Siu Fung and non-executive director Hua Zhangrong as members. • Remuneration Committee: Led by independent director Bau Siu Fung; Sang Yongsheng and Chairman Liao Yu serve as members. • Nomination Committee: Chaired by independent director Sang Yongsheng, joined by Cao Xiaoxue and executive director Tang Taike. • Strategy Committee: Chaired by Liao Yu, with membership comprising Cao Xiaoxue, Liu Bo, Hua Zhangrong and Luo Tian.

The updated list underscores the company’s adherence to a diversified board structure with equal representation of executive, non-executive and independent non-executive directors across its four specialized committees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10